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ABSTRACT 
Mammary tumors are among the most common neoplastic conditions in dogs, and there is 
evidence that inflammation plays a role in the development of some tumor types in dogs. The 
complement system is a major participant in the inflammatory process and the complement 
activation component, C5a, is a potent inflammatory peptide. This study investigated the 
mRNA expression of the major receptor for C5a (C5aR; CD88) in histopathological samples 
of canine mammary tumors by quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR) using canine-specific primers for CD88. A total of seven canine mammary 
tumors (four malignant carcinomas, two benign mixed mammary tumors, and one 
myoepithelioma) and eight normal mammary glands were analysed. All the tumor samples 
expressed low levels of CD88 mRNA, while none of the normal mammary tissues showed 
any detectable expression. These preliminary results suggest that C5a–CD88 interaction may 
play a contributory role in the inflammatory response associated with mammary tumor 
development in dogs. Further studies investigating the mechanisms behind complement 
activation and C5a receptor expression in canine mammary tumors are warranted 
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